Takeda Pharmaceutical Company (TKDA) Revenue

4 Followers

Takeda Pharmaceutical Company Revenue

Takeda Pharmaceutical Company had a revenue of 1.22T in the quarter ending Jun 30, 2026, with 9.44%. This bring the company's revenue in the last twelve months to 4.66T, Decreased 2.49%. In the fiscal year ending Mar 31, 2026, Takeda Pharmaceutical Company had annual revenue of 4.78T with 4.28% growth.

Revenue (ttm)

4.66T

Revenue Growth

-6.84%

P/S Ratio

0.01

Revenue/Employee

€101,585,198

Employees

47,029

Market Cap

€50.36B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Mar 31, 2026	4.78T	195.90B	+4.28%
Mar 31, 2025	4.58T	317.79B	+7.45%
Mar 31, 2024	4.26T	236.28B	+5.87%
Mar 31, 2023	4.03T	458.47B	+12.85%
Mar 31, 2022	3.57T	371.19B	+11.61%
Mar 31, 2021	3.20T	-93.38B	-2.84%
Mar 31, 2020	3.29T	1.19T	+56.93%
Mar 31, 2019	2.10T	326.69B	+18.45%
Mar 31, 2018	1.77T	―	―